Macrolide resistance mechanisms and in vitro susceptibility patterns of viridans group streptococci isolated from blood cultures

Journal of Antimicrobial Chemotherapy

Volumn 57, Issue 1, 2006, Pages 139-141

  Ergin, Alper ^a   Ercis, Serpil ^a   Hasçelik, Gülşen ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

erm(B); Erythromycin resistance; M phenotype; Mef(A); MLSB; S. oralis

Indexed keywords

BACTERIAL PROTEIN; CHLORAMPHENICOL; CLINDAMYCIN; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; LEVOFLOXACIN; LINCOSAMIDE; LINEZOLID; MACROLIDE; PENICILLIN G; PROTEIN ERMB; PROTEIN MEFA; STREPTOGRAMIN; TETRACYCLINE; UNCLASSIFIED DRUG; VANCOMYCIN;

AGAR MEDIUM; ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM CULTURE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; DILUTION; GENE FREQUENCY; GENOTYPE; IN VITRO STUDY; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; STREPTOCOCCUS ORALIS;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; GENOTYPE; HUMANS; MACROLIDES; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; STREPTOCOCCAL INFECTIONS; VIRIDANS STREPTOCOCCI;

EID: 30344437587     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dki404     Document Type: Article

References (10)

1. Smith A, Jackson MS, Kennedy H. Antimicrobial susceptibility of viridans group streptococcal blood isolates to eight antimicrobial agents. Scand J Infect Dis 2004; 36: 259-63.
2. Seppala H, Haanpera M, Al-Juhaish M et al. Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from normal flora. J Antimicrob Chemother 2003; 52: 636-44.
3. Zolezzi PC, Laplana LM, Calvo CR et al. Molecular basis of resistance to macrolides and other antibiotics in commensal viridans group streptococci and Gemella spp. and transfer of resistance genes to Streptococcus pneumoniae. Antimicrob Agents Chemother 2004; 48: 3462-7.
4. Facklam R. What happened to the streptococci: Overview of the taxonomic and nomenclature changes. Clin Microbiol Rev 2002; 15: 613-30.
5. Clinical and Laboratory Standards Institute (formerly NCCLS). Performance Standards for Antimicrobial Susceptibility Testing; Fifteenth Informational Supplement: M100-S15. CLSI, Wayne, PA, USA, 2005.
6. Sutcliffe J, Grebe T, Tait-Kamradt A et al. Detection of erythromycin-resistant determinants by PCR. Antimicrob Agents Chemother 1996; 40: 2562-6.
7. Seppala H, Skurnik M, Soini H et al. A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes. Antimicrob Agents Chemother 1998; 42: 257-62.
8. Rodriguez-Avial I, Rodriguez-Avial C, Culebras E et al. In vitro activity of telithromycin against viridans group streptococci and Streptococcus bovis isolated from blood: Antimicrobial susceptibility patterns in different groups of species. Antimicrob Agents Chemother 2005; 49: 820-3.
9. Uh Y, Shin DH, Jang IH et al. Antimicrobial susceptibility patterns and macrolide resistance genes of viridans streptococci from blood cultures in Korea. J Antmicrob Chemother 2004; 53: 1095-7.
10. Achour W, Guenni O, Malbruny B et al. Phenotypic and molecular characterization of macrolide and streptogramin resistance in Streptococcus mitis from neutropenic patients. J Antimicrob Chemother 2004; 54: 117-21.